A Randomized Phase II Study of Durvalumab and Tremelimumab Compared to Doxorubicin in Patients with Advanced or Metastatic Soft Tissue Sarcoma (Medisarc, AIO-STS-0415)

Authors
Publication date
1 January 2020
Publisher
'S. Karger AG'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:3...
    Last time updated on 08/04/2021